The effect of fluconazole, an antimycotic that inhibits cytochrome P-4
50-mediated drug metabolism, on theophylline kinetics and the producti
on of its metabolites were compared with those of enoxacin in 5 health
y subjects. All subjects received a single oral dose of 240 mg theophy
lline (aminophylline, 300 mg) after they had been given oral fluconazo
le 100 mg every 12 h or enoxacin 200 mg every 8 h for three consecutiv
e days. Pretreatment with enoxacin decreased the total clearance (CL(T
)) and elimination rate constant (K-el) of theophylline by 50 % and 46
%, respectively, without changing the volume of distribution (V-d), b
ut there were no significant change in any pharmacokinetic parameter w
hen fluconazole was administered. Enoxacin led to a 50 % reduction in
the metabolic clearance (CL(M)) of theophylline and to decreases of 69
%, 59 % and 38 % in the formation clearance of the three theophylline
metab elites, 3-methylxanthine (3-MX), 1-methyluric acid (1-MU), and
1,3-dimethyluric acid (1,3-DMU), respectively, accompanied by signific
ant changes in the urinary recovery of theophylline and its metabolite
s. In contrast, treatment with fluconazole led only to a slight decrea
se in the CL, of theophylline (16 %) and in the formation clearance of
its metabolites (15 % - 18 %), and there was no change in the renal c
learance (CL(R)) of theophylline. The results indicate that fluconazol
e is a minor inhibitor of theophylline disposition compared with enoxa
cin, and they suggest that the inhibitory action of fluconazole is sel
ective for certain cytochrome P-450 isozymes, but not for the cytochro
me P-4501A involved in theophylline metabolism.